Effects of Preprotachykinin‐I Peptides on Hematopoietic Homeostasis: A Role for Bone Marrow Endopeptidases

P Gascon,J Qian,DD Joshi,T Teli,A Haider,P Rameshwar
DOI: https://doi.org/10.1111/j.1749-6632.2000.tb05406.x
IF: 6.499
2000-01-01
Annals of the New York Academy of Sciences
Abstract:Abstract: Hematopoiesis is maintained by “fine‐tuned” regulation among cytokines, neuropeptides, neurotransmitters, and neurotrophic factors. Neurotransmitters, derived from PPT‐I exert immune and hematopoietic regulation. PPT‐I is also expressed locally in bone marrow (BM) stromal cells. PPT‐I peptides induce the production of cytokines in BM cells, resulting in regulation of both committed progenitors (CFU‐GM) and primitive hematopoietic progenitors (CAFC). Both types of progenitors are regulated differently by the two major PPT‐I peptides, SP and NK‐A. Endopeptidases, present in BM cells, can digest SP to produce SP(1‐4) and SP(4‐11). In this study, we investigated the hematopoietic effects of these fragments on CFU‐GM and CAFC. Similar to the two major intact PPT‐I peptides (SP and NK‐A), we observed different hematopoietic effects by SP(1‐4) and SP(4‐11). Whereas SP(1‐4) exerted inhibitory effects on CFU‐GM and CAFC, SP(4‐11) mediated stimulatory effects. Similar to NK‐A, the inhibitory effects of SP(1‐4) can be partly explained by the induction of suppressive cytokines (TGF‐β, TNF‐α, and INF‐γ). Use of antagonists and screening of a dodecapeptide expression library determined that the effects of SP(1‐4) were mediated by NK‐1. These results show that PPT‐I peptides and their endopeptidase‐derived fragments may add to the fine‐tuned regulation on hematopoiesis. Furthermore, PPT‐I may be exerting autoregulation to protect hematopoietic stem cells. These studies have relevance to stem cell protection and BM transplant.
What problem does this paper attempt to address?